Please login to the form below

Not currently logged in

Public unaware of main cause of liver cancer

Janssen-backed survey finds one in six people is aware of viral hepatitis role in the disease

liver cancer thumb
Janssen's hepatitis-liver cancer infographic (click on image to see full version)

Just one in six people is aware that the main cause of liver cancer, the sixth most common cancer, is viral hepatitis, according to a survey supported by Janssen EMEA – a subsidiary of Johnson & Johnson (J&J).

Timed to mark Liver Cancer Awareness Month (October) and supported by the World Hepatitis Alliance, the European Liver Patients Association and the International Liver Cancer Association, the survey also found low public awareness of the prevention and treatment of viral hepatitis.

More than 9 out of ten (91 per cent) of the 5,000 people surveyed knew little or nothing about viral hepatitis, with levels of awareness varying across the countries covered. Respondents also lacked understanding of the transmission routes of hepatitis.

Over half (56 per cent) were unsure of the symptoms, prevention and treatment of hepatitis. Just under half (49 per cent) knew that there is a vaccine for hepatitis B, and 45 per cent and 50 per cent, respectively, that hepatitis B and C can be treated.

 In addition, 40 per cent of respondents were unaware that hepatitis C is a potentially curable disease. There was a huge variation in this between countries, with Turkey showing the greatest awareness in this area (76 per cent) and the UK the lowest (48 per cent).

“The lack of public awareness of viral hepatitis is of grave concern,” said Achim Kautz, policy director, European Liver Patients Association.

“To drive improvements in testing and diagnosis rates, improved public awareness about the virus is necessary so that people can assess whether they have been at risk of infection, and come forward for testing,” he added.

22nd October 2013

From: Marketing, Healthcare



Featured jobs

Subscribe to our email news alerts


Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...